IFT88 has also been shown to inhibit Che1, an inhibitor of the Rb tumor suppressor – upon IFT88 ablation, Che1 then inhibits Rb, freeing E2F transcription factors to drive cell cycle progression [169]. This evidence concerns the gene IFT88 and neoplasm.